文献速递物质与行为成瘾

阿托莫西汀降低人类可卡因成瘾者的决策冲动性

Atomoxetine Reduces Decisional Impulsivity in Human Cocaine Addiction.
PubMed 文献 · Biol Psychiatry · 2024-10-29

这项随机、双盲、安慰剂对照交叉研究纳入28例中重度可卡因使用障碍(CUD)患者和28名匹配健康对照,比较单次40 mg阿托莫西汀与安慰剂对剑桥赌博任务决策的影响;结果显示阿托莫西汀选择性降低CUD患者的决策冲动性,对健康对照的冲动性无影响。

要点

  • CUD患者在决策的价值、概率和决策冲动性3个成分上均受损。
  • 单次40 mg阿托莫西汀选择性降低CUD患者的决策冲动性,减少其冒险倾向并提高延迟耐受能力。
  • 阿托莫西汀未影响健康对照的冲动性,但增加其对预期损失的敏感性。

核心结论

  • 研究结果支持CUD患者存在去甲肾上腺素能功能障碍的假说,并为阿托莫西汀改善CUD决策冲动性提供转化证据。

研究设计与样本

  • 随机、双盲、安慰剂对照交叉研究,纳入28例中重度CUD患者和28名匹配健康对照,两个独立访视分别接受安慰剂或单次40 mg阿托莫西汀,完成剑桥赌博任务,并用计算建模分解决策成分。

主要发现

  • CUD患者在决策的价值、概率和决策冲动性3个成分上均受损。
  • 阿托莫西汀选择性降低CUD患者的决策冲动性,降低其冒险倾向并增强其延迟耐受能力。
  • 阿托莫西汀未影响健康对照参与者的冲动性,但增加其对预期损失的敏感性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Impulsivity is a well-known determinant of maladaptive behavior in cocaine use disorder (CUD), but there are currently no effective strategies for managing excessive impulsivity. Growing evidence from preclinical and clinical studies suggests that atomoxetine, a selective noradrenaline reuptake inhibitor, is effective in improving impulse control in both healthy individuals and individuals with neuropsychiatric conditions. METHODS: We investigated the effects of atomoxetine on decisional impulsivity in patients with CUD. In a randomized, double-blind, placebo-controlled, crossover study, 28 patients diagnosed with moderate-to-severe CUD and 28 matched healthy control participants completed the Cambridge Gambling Task in 2 separate sessions, where they received either placebo or a single dose of 40 mg atomoxetine at each session. Computational modeling was used to break down decision making into 3 separable components: value, probability, and decisional impulsivity. RESULTS: Our analyses revealed that patients with CUD were impaired in all components of decision making. Atomoxetine selectively reduced decisional impulsivity in patients with CUD by reducing their risk-seeking tendencies while enhancing their ability to tolerate delays. By contrast, atomoxetine did not affect impulsivity in control participants, but increased their sensitivity to prospective losses. CONCLUSIONS: Taken together, our findings support the hypothesis of noradrenergic dysfunction in patients with CUD and provide novel translational evidence for the efficacy of atomoxetine in remediating decisional impulsivity in CUD.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Lim TV, Cardinal RN, Ziauddeen H, et al. Atomoxetine Reduces Decisional Impulsivity in Human Cocaine Addiction. Biol Psychiatry. 2024. PMID: 39481776. doi:10.1016/j.biopsych.2024.10.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。